70 Empl. Prac. Dec. P 44,681, Medicare & Medicaid Guide P 44,681 Doretha Wooten v. Roche Biomedical Laboratories, Incorporated

96 F.3d 1440
CourtCourt of Appeals for the Fourth Circuit
DecidedApril 9, 1997
Docket95-2458
StatusUnpublished

This text of 96 F.3d 1440 (70 Empl. Prac. Dec. P 44,681, Medicare & Medicaid Guide P 44,681 Doretha Wooten v. Roche Biomedical Laboratories, Incorporated) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
70 Empl. Prac. Dec. P 44,681, Medicare & Medicaid Guide P 44,681 Doretha Wooten v. Roche Biomedical Laboratories, Incorporated, 96 F.3d 1440 (4th Cir. 1997).

Opinion

96 F.3d 1440

70 Empl. Prac. Dec. P 44,681,
Medicare & Medicaid Guide P 44,681
NOTICE: Fourth Circuit Local Rule 36(c) states that citation of unpublished dispositions is disfavored except for establishing res judicata, estoppel, or the law of the case and requires service of copies of cited unpublished dispositions of the Fourth Circuit.
Doretha WOOTEN, Plaintiff-Appellant,
v.
ROCHE BIOMEDICAL LABORATORIES, INCORPORATED, Defendant-Appellee.

No. 95-2458.

United States Court of Appeals,
Fourth Circuit.

Argued March 4, 1996.
Decided Sept. 11, 1996.
Order Vacating Opinion in Part April 9, 1997 and reissuing
mandate nunc pro tunc Oct. 3, 1996.

ARGUED: Nancy Pulliam Quinn, DAVID & QUINN, Greensboro, North Carolina, for Appellant. Gregory Phillip McGuire, HAYNSWORTH, BALDWIN, JOHNSON & GREAVES, P.A., Greensboro, North Carolina, for Appellee.

M.D.N.C.

AFFIRMED.

Before NIEMEYER and MOTZ, Circuit Judges, and BUTZNER, Senior Circuit Judge.

OPINION

PER CURIAM:

Doretha Wooten sued Roche Biomedical Laboratories under Title VII, claiming discriminatory treatment in the company's failure to promote her. The district court granted summary judgment against Wooten. We affirm.

* Wooten began working for Roche Biomedical Laboratories in 1981. For a period of 12 years, she held a variety of jobs with the company. In 1989, she became a Quality Control Technician in the Special Products Department, under the supervision of Billy Fox. In early 1993, the company underwent a reorganization, and Pam Turpin became Wooten's supervisor.

During her time as Quality Control Technician, Wooten received numerous reprimands for tardiness, attendance problems, and poor work performance. Between April and October 1993, she received three written disciplinary actions for infractions. Because Wooten was taking college classes, Roche allowed her to work on a flexible timetable and to reschedule her work hours. Yet Wooten could not meet even this lenient schedule. During a span of eight and one half months in 1993, Wooten was late by more than 10 minutes on 49 occasions, significantly more than the next most tardy employee. Wooten also received disciplinary actions for work errors. In one instance in April 1993, Wooten claimed to have processed serum between 1:00 p.m. and 1:30 p.m. Her time card revealed that she did not show up for work until 1:32 p.m. As a result of the falsification, the entire lot of serum on which she was working had to be destroyed. Besides losing the product, Roche could have faced criminal charges of fraudulent activity based on this action. On January 4, 1994, Wooten took a medical leave of absence. On July 14, 1994, Roche terminated Wooten for failing to return to work after her leave of absence had expired.

Wooten brought this action under Title VII, claiming discrimination in Roche's failure to promote her to two positions: Red Blood Cell Supervisor and Quality Assurance Supervisor. She also claimed discriminatory treatment in being disciplined and alleged that Roche breached an implied covenant of good faith and fair dealing under North Carolina law. A magistrate judge recommended granting Roche's motion for summary judgment on all claims, and the district court affirmed.

II

We review grants of summary judgment de novo. Shaw v. Stroud, 13 F.3d 791, 798 (4th Cir.1994). Summary judgment should be granted only if there is no genuine issue of material fact. Fed.R.Civ.P. 56(c); Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 247-50 (1986). In considering the evidence, all reasonable inferences are to be drawn in favor of the nonmoving party. Id. at 255. A court may grant summary judgment against a party that fails to establish sufficiently the existence of an element essential to the party's case and on which the party will bear the burden of proof at trial. Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1986).

In McDonnell Douglas Corp. v. Green, 411 U.S. 792 (1973), the Court developed a scheme allocating the burdens of proof in a Title VII case alleging discrimination. First, by a preponderance of the evidence, the plaintiff must prove a prima facie case of discrimination. Texas Dept. of Community Affairs v. Burdine, 450 U.S. 248, 252-53 (1981). A prima facie case requires the plaintiff to show that: (1) she belongs to a class protected under Title VII; (2) she applied and was qualified for a position for which the employer was seeking applications; (3) she was rejected from this position; and (4) after the rejection, the position remained open and the employer continued to seek applicants from among those with plaintiff's qualifications. See Green, 411 U.S. at 802. Once the plaintiff proves this case, the burden shifts to the defendant to articulate a legitimate nondiscriminatory reason for the rejection. Id. If the defendant meets this hurdle, then the plaintiff may show that the defendant's stated reason for rejection was pretextual by showing that the proffered reason was false and that discrimination was the real reason for rejection. St. Mary's Honor Center v. Hicks, 113 S.Ct. 2742, 2751-52 (1993). At all times, "the plaintiff has the ultimate burden of persuading the trier of fact that the defendant intentionally discriminated against the plaintiff." Burdine, 450 U.S. at 253.

Wooten fails to make out a prima facie case for either of the two positions for which she claims discrimination. She fails to show either the second or third elements of the case, as she neither applied for, nor was rejected from, the position of Red Blood Cell Production Supervisor. This position was created not by a vacancy, but instead by a reorganization of the company. Pam Turpin, who received this position, kept her old job title and salary.

Nor can Wooten prove a prima facie case for the position of Quality Assurance Supervisor, for which she made no showing that she was qualified. For this position, Roche was seeking an employee with experience in quality assurance and in working with a company regulated by the Food and Drug Administration (FDA). Julie Weintraub, who received the position, had been a Quality Assurance technician at QUIDEL Corporation, an FDA-regulated company. Not only did Wooten lack experience in quality assurance but her company had not been regulated by the FDA during her tenure.

Even if Wooten could make out a prima facie case under Title VII, Roche satisfied its burden of rebuttal by articulating legitimate nondiscriminatory reasons for its decisions. Again, Turpin's accession to Red Blood Cell Supervisor was a lateral transfer, not a promotion. And only Weintraub, not Wooten, had the experience Roche was seeking in its Quality Assurance Supervisor position.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Texas Department of Community Affairs v. Burdine
450 U.S. 248 (Supreme Court, 1981)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
St. Mary's Honor Center v. Hicks
509 U.S. 502 (Supreme Court, 1993)
Curtiss L. Cook v. Csx Transportation Corporation
988 F.2d 507 (Fourth Circuit, 1993)
Salt v. Applied Analytical, Inc.
412 S.E.2d 97 (Court of Appeals of North Carolina, 1991)
Shaw v. Stroud
13 F.3d 791 (Fourth Circuit, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
96 F.3d 1440, Counsel Stack Legal Research, https://law.counselstack.com/opinion/70-empl-prac-dec-p-44681-medicare-medicaid-guide-p-ca4-1997.